Your browser doesn't support javascript.
loading
Diagnostic amyloid proteomics: experience of the UK National Amyloidosis Centre.
Canetti, Diana; Rendell, Nigel B; Gilbertson, Janet A; Botcher, Nicola; Nocerino, Paola; Blanco, Angel; Di Vagno, Lucia; Rowczenio, Dorota; Verona, Guglielmo; Mangione, P Patrizia; Bellotti, Vittorio; Hawkins, Philip N; Gillmore, Julian D; Taylor, Graham W.
Afiliação
  • Canetti D; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Rendell NB; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Gilbertson JA; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Botcher N; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Nocerino P; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Blanco A; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Di Vagno L; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Rowczenio D; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Verona G; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Mangione PP; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Bellotti V; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy.
  • Hawkins PN; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
  • Gillmore JD; Department of Molecular Medicine, Institute of Biochemistry, University of Pavia, Pavia, Italy.
  • Taylor GW; Wolfson Drug Discovery Unit and National Amyloidosis Centre, Centre for Amyloidosis and Acute Phase Proteins, Division of Medicine, University College London, London, UK.
Clin Chem Lab Med ; 58(6): 948-957, 2020 06 25.
Article em En | MEDLINE | ID: mdl-32069225
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteômica / Proteínas Amiloidogênicas / Amiloidose Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteômica / Proteínas Amiloidogênicas / Amiloidose Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2020 Tipo de documento: Article